Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 8 | $1.02 | $1.13 | $1.07 |
| Q2 2026 | 7 | $1.08 | $1.17 | $1.12 |
| Q3 2026 | 2 | $1.15 | $1.20 | $1.18 |
| Q4 2026 | 2 | $1.12 | $1.16 | $1.14 |
| Q1 2027 | 2 | $1.15 | $1.20 | $1.17 |
| Q2 2027 | 5 | $1.21 | $1.26 | $1.23 |
| Q3 2027 | 4 | $1.28 | $1.34 | $1.31 |
| Q4 2027 | 3 | $1.22 | $1.27 | $1.24 |
| Q1 2028 | 4 | $1.23 | $1.28 | $1.25 |
| Q2 2028 | 3 | $1.25 | $1.31 | $1.28 |
| Q3 2028 | 3 | $1.35 | $1.41 | $1.38 |
Hologic, Inc. last posted its earnings results on Thursday, January 29th, 2026. The company reported $1.04 earnings per share for the quarter, missing analysts' consensus estimates of $1.09 by $0.05. The company had revenue of 1.05 B for the quarter and had revenue of 4.10 B for the year. Hologic, Inc. has generated $3 earnings per share over the last year ($2.49 diluted earnings per share) and currently has a price-to-earnings ratio of 31.1. Hologic, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 01/29/2026 | Q1 2026 | $1.09 | $0.80 | -0.29 | $1.07 B | $1.05 B |
| 11/18/2025 | Q4 2025 | N/A | $0.84 | N/A | $1.03 B | $1.05 B |
| 07/31/2025 | Q3 2025 | N/A | $0.87 | N/A | N/A | $1.02 B |
| 05/02/2025 | Q2 2025 | N/A | -$0.08 | N/A | N/A | $1.01 B |
| 02/06/2025 | Q1 2025 | N/A | $0.87 | N/A | N/A | $1.02 B |
| 11/27/2024 | Q4 2024 | N/A | $0.76 | N/A | N/A | $988.00 M |
| 07/30/2024 | Q3 2024 | N/A | $0.83 | N/A | N/A | $1.01 B |
| 05/03/2024 | Q2 2024 | N/A | $0.72 | N/A | N/A | $1.02 B |
| 02/02/2024 | Q1 2024 | N/A | $1.03 | N/A | N/A | $1.01 B |
| 11/21/2023 | Q4 2023 | N/A | $0.37 | N/A | N/A | $945.30 M |
| 08/01/2023 | Q3 2023 | N/A | -$0.16 | N/A | N/A | $984.40 M |
| 05/02/2023 | Q2 2023 | N/A | $0.88 | N/A | N/A | $1.03 B |
| 02/01/2023 | Q1 2023 | $0.90 | $0.76 | -0.14 | N/A | $1.07 B |
| 11/15/2022 | Q4 2022 | N/A | $0.47 | N/A | N/A | $953.20 M |
| 07/27/2022 | Q3 2022 | $0.71 | $0.91 | 0.2 | N/A | $1.00 B |
| 04/27/2022 | Q2 2022 | $1.60 | $1.81 | 0.21 | $1.29 B | $1.44 B |
| 02/02/2022 | Q1 2022 | $1.28 | $1.97 | 0.69 | N/A | $1.47 B |
| 11/16/2021 | Q4 2021 | N/A | $1.29 | N/A | N/A | $1.32 B |
| 07/28/2021 | Q3 2021 | $1.12 | $1.05 | -0.07 | $1.04 B | $1.17 B |
| 04/28/2021 | Q2 2021 | $2.62 | $2.40 | -0.22 | N/A | $1.54 B |
The conference call for Hologic, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Hologic, Inc.'s latest earnings report can be read online.
Hologic, Inc. (:HOLX) has a recorded annual revenue of $4.10 B.
Hologic, Inc. (:HOLX) has a recorded net income of $565.70 M.Hologic, Inc. has generated $2.5 earnings per share over the last four quarters.
Hologic, Inc. (:HOLX) has a price-to-earnings ratio of 31.1 and price/earnings-to-growth ratio is -11.11.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED